Comparison of beta-blocker effectiveness in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction

Journal of Cardiac Failure

Volumn 19, Issue 2, 2013, Pages 73-79

  El Refai, Mostafa ^a   Peterson, Edward L ^a   Wells, Karen ^a   Swadia, Tanmay ^a   Sabbah, Hani N ^a   Spertus, John A ^b   Williams, L Keoki ^a   Lanfear, David E ^a  

^a HENRY FORD HOSPITAL   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Beta adrenergic receptor blocker; diastolic dysfunction; heart failure with preserved ejection fraction; hospitalization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LABETALOL; METOPROLOL;

AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84873336314     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.11.011     Document Type: Article

References (26)

1. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. de Marco, and G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database J Am Coll Cardiol 47 2006 76 84
2. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
3. S.M. Farasat, D.T. Bolger, and V. Shetty Effect of beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction Am J Cardiol 105 2010 229 234
4. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225
5. A.F. Hernandez, B.G. Hammill, C.M. O'Connor, K.A. Schulman, L.H. Curtis, and G.C. Fonarow Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry J Am Coll Cardiol 53 2009 184 192
6. S. Tamaki, Y. Sakata, and T. Mano Long-term beta-blocker therapy improves diastolic function even without the therapeutic effect on systolic function in patients with reduced ejection fraction J Cardiol 56 2010 176 182
7. D.J. van Veldhuisen, A. Cohen-Solal, and M. Bohm Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
8. B.M. Massie, J.J. Nelson, and M.A. Lukas Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice Am J Cardiol 99 2007 1263 1268
9. D.T. Smith, R. Farzaneh-Far, S. Ali, B. Na, M.A. Whooley, and N.B. Schiller Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study) Am J Cardiol 105 2010 223 228
10. A. Bergstrom, B. Andersson, M. Edner, E. Nylander, H. Persson, and U. Dahlstrom Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-Echocardiographic study (SWEDIC) Eur J Heart Fail 6 2004 453 461
11. L.K. Williams, E.L. Peterson, and K. Wells Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence J Allergy Clin Immunol 128 2011 1185 1191
12. Z.A. Habib, S.L. Havstad, K. Wells, G. Divine, M. Pladevall, and L.K. Williams Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 95 2010 592 600
13. D.E. Lanfear, T. Hrobowski, and E.L. Peterson Association of beta blocker exposure with outcomes in heart failure differs between African American and White patients Circ Heart Fail 5 2012 202 208
14. D.E. Lanfear, E. Peterson, K. Wells, and L.K. Williams Discharge medication status compares poorly with claims-based outpatient medication exposure estimates. AHA Quality of Care and Outcomes Research 2011 American Heart Association Washington, DC
15. F. Alqaisi, L.K. Williams, E.L. Peterson, and D.E. Lanfear Comparing methods for identifying patients with heart failure using electronic data sources BMC Health Serv Res 9 2009 237
16. W.Y. Lee, A.M. Capra, N.G. Jensvold, J.H. Gurwitz, and A.S. Go Gender and risk of adverse outcomes in heart failure Am J Cardiol 94 2004 1147 1152
17. B.B. Granger, K. Swedberg, and I. Ekman Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial Lancet 366 2005 2005 2011
18. J.L. Fleiss, B.A. Levin, and M.C. Paik Statistical methods for rates and proportions 3rd ed. 2003 J. Wiley Hoboken, NJ
19. R. Nevzorov, A. Porath, Y. Henkin, S.L. Kobal, A. Jotkowitz, and V. Novack Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure Eur J Intern Med 23 2012 374 378
20. S. Ather, W. Chan, and B. Bozkurt Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
21. M. Fu, J. Zhou, and A. Sun Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction - a meta analysis of 7 prospective clinical studies Int J Cardiol 155 2012 33 38
22. S.B. Pereira, M.W. Velloso, and S. Chermont Beta-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: Implication of ethnicity Mol Med Report 7 2012 259 265
23. B.J. Hirsh, A. Mignatti, and A.R. Garan Effect of beta-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure Circ Heart Fail 5 2012 560 565
24. D. Cullington, K.M. Goode, A.L. Clark, and J.G. Cleland Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target? Eur J Heart Fail 14 2012 737 747
25. M. Fiuzat, D. Wojdyla, and D. Kitzman Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial J Am Coll Cardiol 60 2012 208 215
26. A. Schulz, B. Israel, D. Williams, E. Parker, A. Becker, and S. James Social inequalities, stressors and self reported health status among African American and White women in the Detroit metropolitan area Soc Sci Med 51 2000 1639 1653